Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

10
(from Reference Citation Analysis)

Article PDFs (2)

Cited by > 0 (6)

Searched Name

Paul E Kearney

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Hirst JE, Boniface JJ, Le DP, Polpitiya AD, Fox AC, Vu TTK, Dang TT, Fleischer TC, Bui NTH, Hickok DE, Kearney PE, Thwaites G, Kennedy SH, Kestelyn E, Le TQ. Validating the ratio of insulin like growth factor binding protein 4 to sex hormone binding globulin as a prognostic predictor of preterm birth in Viet Nam: a case-cohort study. J Matern Fetal Neonatal Med 2024;37:2333923. [PMID: 38584143 DOI: 10.1080/14767058.2024.2333923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2023] [Accepted: 03/13/2024] [Indexed: 04/09/2024]

Burchard J, Saade GR, Boggess KA, Markenson GR, Iams JD, Coonrod DV, Pereira LM, Hoffman MK, Polpitiya AD, Treacy R, Fox AC, Randolph TL, Fleischer TC, Dufford MT, Garite TJ, Critchfield GC, Boniface JJ, Kearney PE. Better Estimation of Spontaneous Preterm Birth Prediction Performance through Improved Gestational Age Dating. J Clin Med 2022;11:jcm11102885. [PMID: 35629011 PMCID: PMC9146613 DOI: 10.3390/jcm11102885] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2022] [Revised: 05/11/2022] [Accepted: 05/18/2022] [Indexed: 02/05/2023] Open

Affiliation(s)

Julja Burchard Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.) Correspondence: ; Tel.: +1-801-990-0597
George R. Saade Department of Obstetrics & Gynecology, The University of Texas Medical Branch, Galveston, TX 77555, USA;
Kim A. Boggess Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of North Carolina, Chapel Hill, NC 27599, USA;
Glenn R. Markenson Maternal Fetal Medicine, Boston University School of Medicine, Boston, MA 02118, USA;
Jay D. Iams Department of Obstetrics & Gynecology, The Ohio State University, Columbus, OH 43210, USA;
Dean V. Coonrod Department of Obstetrics and Gynecology, Valleywise Health, Phoenix, AZ 85008, USA;
Leonardo M. Pereira Division of Maternal-Fetal Medicine, Oregon Health & Science University, Portland, OR 97239, USA;
Matthew K. Hoffman Department of Obstetrics & Gynecology, Christiana Care Health System, Newark, DE 19718, USA;
Ashoka D. Polpitiya Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Ryan Treacy Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Angela C. Fox Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Todd L. Randolph Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Tracey C. Fleischer Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Max T. Dufford Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Thomas J. Garite Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Gregory C. Critchfield Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
J. Jay Boniface Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Paul E. Kearney Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (A.D.P.); (R.T.); (A.C.F.); (T.L.R.); (T.C.F.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)

Collapse

Burchard J, Markenson GR, Saade GR, Laurent LC, Heyborne KD, Coonrod DV, Schoen CN, Baxter JK, Haas DM, Longo SA, Sullivan SA, Wheeler SM, Pereira LM, Boggess KA, Hawk AF, Crockett AH, Treacy R, Fox AC, Polpitiya AD, Fleischer TC, Garite TJ, Jay Boniface J, Zupancic JAF, Critchfield GC, Kearney PE. Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohort. J Med Econ 2022;25:1255-1266. [PMID: 36377363 DOI: 10.1080/13696998.2022.2147771] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Abstract

OBJECTIVES

Preterm birth occurs in more than 10% of U.S. births and is the leading cause of U.S. neonatal deaths, with estimated annual costs exceeding $25 billion USD. Using real-world data, we modeled the potential clinical and economic utility of a prematurity-reduction program comprising screening in a racially and ethnically diverse population with a validated proteomic biomarker risk predictor, followed by case management with or without pharmacological treatment.

METHODS

The ACCORDANT microsimulation model used individual patient data from a prespecified, randomly selected sub-cohort (N = 847) of a multicenter, observational study of U.S. subjects receiving standard obstetric care with masked risk predictor assessment (TREETOP; NCT02787213). All subjects were included in three arms across 500 simulated trials: standard of care (SoC, control); risk predictor/case management comprising increased outreach, education and specialist care (RP-CM, active); and multimodal management (risk predictor/case management with pharmacological treatment) (RP-MM, active). In the active arms, only subjects stratified as higher risk by the predictor were modeled as receiving the intervention, whereas lower-risk subjects received standard care. Higher-risk subjects' gestational ages at birth were shifted based on published efficacies, and dependent outcomes, calibrated using national datasets, were changed accordingly. Subjects otherwise retained their original TREETOP outcomes. Arms were compared using survival analysis for neonatal and maternal hospital length of stay, bootstrap intervals for neonatal cost, and Fisher's exact test for neonatal morbidity/mortality (significance, p < .05).

RESULTS

The model predicted improvements for all outcomes. RP-CM decreased neonatal and maternal hospital stay by 19% (p = .029) and 8.5% (p = .001), respectively; neonatal costs' point estimate by 16% (p = .098); and moderate-to-severe neonatal morbidity/mortality by 29% (p = .025). RP-MM strengthened observed reductions and significance. Point estimates of benefit did not differ by race/ethnicity.

CONCLUSIONS

Modeled evaluation of a biomarker-based test-and-treat strategy in a diverse population predicts clinically and economically meaningful improvements in neonatal and maternal outcomes.

Collapse

Affiliation(s)

Julja Burchard Sera Prognostics, Inc, Salt Lake City, UT, USA
Glenn R Markenson Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA, USA
George R Saade Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, USA
Louise C Laurent Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, CA, USA
Kent D Heyborne Department of Obstetrics and Gynecology, Denver Health and Hospital Authority, Denver, CO, and Department of Obstetrics and Gynecology, University of Colorado Denver, Aurora, CO, USA
Dean V Coonrod Department of Obstetrics and Gynecology, Valleywise Health, and Department of Obstetrics and Gynecology, University of Arizona College of Medicine, Phoenix, AZ, USA
Corina N Schoen Department of Obstetrics and Gynecology, University of Massachusetts-Baystate, Springfield, MA, USA
Jason K Baxter Department of Obstetrics and Gynecology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA
David M Haas Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA
Sherri A Longo Department of Obstetrics and Gynecology, Ochsner Health, New Orleans, LA, USA
Scott A Sullivan Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC, USA
Sarahn M Wheeler Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC, USA
Leonardo M Pereira Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA
Kim A Boggess Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, NC, USA
Angela F Hawk Regional Obstetrical Consultants, Chattanooga, TN, USA
Amy H Crockett Department of Obstetrics and Gynecology, University of South Carolina School of Medicine Greenville and Prisma Health-Upstate, Greenville, SC, USA
Ryan Treacy Sera Prognostics, Inc, Salt Lake City, UT, USA
Angela C Fox Sera Prognostics, Inc, Salt Lake City, UT, USA
Ashoka D Polpitiya Sera Prognostics, Inc, Salt Lake City, UT, USA
Tracey C Fleischer Sera Prognostics, Inc, Salt Lake City, UT, USA
Thomas J Garite Sera Prognostics, Inc, Salt Lake City, UT, USA
J Jay Boniface Sera Prognostics, Inc, Salt Lake City, UT, USA
John A F Zupancic Department of Pediatrics, Harvard Medical School, and Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA, USA
Gregory C Critchfield Sera Prognostics, Inc, Salt Lake City, UT, USA
Paul E Kearney Sera Prognostics, Inc, Salt Lake City, UT, USA

Collapse

Burchard J, Polpitiya AD, Fox AC, Randolph TL, Fleischer TC, Dufford MT, Garite TJ, Critchfield GC, Boniface JJ, Saade GR, Kearney PE. Clinical Validation of a Proteomic Biomarker Threshold for Increased Risk of Spontaneous Preterm Birth and Associated Clinical Outcomes: A Replication Study. J Clin Med 2021;10:5088. [PMID: 34768605 PMCID: PMC8584743 DOI: 10.3390/jcm10215088] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Revised: 10/20/2021] [Accepted: 10/22/2021] [Indexed: 12/22/2022] Open

Affiliation(s)

Julja Burchard Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (J.B.); (A.D.P.); (A.C.F.); (T.L.R.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Ashoka D. Polpitiya Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (J.B.); (A.D.P.); (A.C.F.); (T.L.R.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Angela C. Fox Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (J.B.); (A.D.P.); (A.C.F.); (T.L.R.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Todd L. Randolph Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (J.B.); (A.D.P.); (A.C.F.); (T.L.R.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Tracey C. Fleischer Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (J.B.); (A.D.P.); (A.C.F.); (T.L.R.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Max T. Dufford Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (J.B.); (A.D.P.); (A.C.F.); (T.L.R.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Thomas J. Garite Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (J.B.); (A.D.P.); (A.C.F.); (T.L.R.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
Gregory C. Critchfield Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (J.B.); (A.D.P.); (A.C.F.); (T.L.R.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
J. Jay Boniface Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (J.B.); (A.D.P.); (A.C.F.); (T.L.R.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)
George R. Saade Department of Obstetrics & Gynecology, University of Texas Medical Branch, Galveston, TX 77555, USA;
Paul E. Kearney Sera Prognostics, Incorporated, Salt Lake City, UT 84109, USA; (J.B.); (A.D.P.); (A.C.F.); (T.L.R.); (M.T.D.); (T.J.G.); (G.C.C.); (J.J.B.); (P.E.K.)

Collapse

Burchard J, Boggess KA, Sullivan SA, Markenson GR, Iams JD, Coonrod DV, Pereira LM, Esplin MS, Lam GK, Hoffman MK, Critchfield GC, Fox AC, Dufford MT, Gravett MG, Kearney PE, Treacy RM, Boniface JJ, Hickok DE, Saade GR. 128: Uncertainty in gestational age dating impacts diagnosis of complications. Am J Obstet Gynecol 2018. [DOI: 10.1016/j.ajog.2017.10.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]

Saade GR, Boggess KA, Sullivan SA, Markenson GR, Iams JD, Coonrod DV, Pereira LM, Esplin MS, Cousins LM, Lam GK, Hoffman MK, Fox AC, Lueth AJ, Hsu C, Dykes A, Dufford MT, Polpitiya AD, Kearney PE, Randolph TL, Boniface JJ, Hickok DE, Fleischer TC. 356: PPROM and PTL phenotypes are characterized by differences in underlying biochemical pathways. Am J Obstet Gynecol 2017. [DOI: 10.1016/j.ajog.2016.11.614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]

Boggess K, Saade GR, Sullivan SA, Markenson GR, Iams JD, Coonrod DV, Pereira LM, Esplin MS, Cousins LM, Lam GK, Hoffman MK, Fox AC, Lueth AJ, Hsu C, Dufford MT, Fleischer TC, Polpitiya AD, Kearney PE, Hickok DE, Boniface JJ, Randolph TL. 337: Use of a second trimester serum-based proteomic risk classifier for prediction of spontaneous and medically-indicated preterm birth. Am J Obstet Gynecol 2017. [DOI: 10.1016/j.ajog.2016.11.595] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]

Kearney PE, Murray PJ, Hoy JM, Hohenhaus M, Kotze A. The 'Toolbox' of strategies for managing Haemonchus contortus in goats: What's in and what's out. Vet Parasitol 2016;220:93-107. [PMID: 26995728 DOI: 10.1016/j.vetpar.2016.02.028] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2015] [Revised: 02/19/2016] [Accepted: 02/25/2016] [Indexed: 10/22/2022]

Abstract

A dynamic and innovative approach to managing the blood-consuming nematode Haemonchus contortus in goats is critical to crack dependence on veterinary anthelmintics. H. contortus management strategies have been the subject of intense research for decades, and must be selected to create a tailored, individualized program for goat farms. Through the selection and combination of strategies from the Toolbox, an effective management program for H. contortus can be designed according to the unique conditions of each particular farm. This Toolbox investigates strategies including vaccines, bioactive forages, pasture/grazing management, behavioural management, natural immunity, FAMACHA, Refugia and strategic drenching, mineral/vitamin supplementation, copper Oxide Wire Particles (COWPs), breeding and selection/selecting resistant and resilient individuals, biological control and anthelmintic drugs. Barbervax(®), the ground-breaking Haemonchus vaccine developed and currently commercially available on a pilot scale for sheep, is prime for trialling in goats and would be an invaluable inclusion to this Toolbox. The specialised behaviours of goats, specifically their preferences to browse a variety of plants and accompanying physiological adaptations to the consumption of secondary compounds contained in browse, have long been unappreciated and thus overlooked as a valuable, sustainable strategy for Haemonchus management. These strategies are discussed in this review as to their value for inclusion into the 'Toolbox' currently, and the future implications of ongoing research for goat producers. Combining and manipulating strategies such as browsing behaviour, pasture management, bioactive forages and identifying and treating individual animals for haemonchosis, in addition to continuous evaluation of strategy effectiveness, is conducted using a model farm scenario. Selecting strategies from the Toolbox, with regard to their current availability, feasibility, economical cost and potential ease of implementation depending on the systems of production and their complementary nature, is the future of managing H. contortus in farmed goats internationally and maintaining the remaining efficacy of veterinary anthelmintics.

Collapse

Kearney PE. A six-point condition for ordinal matrices. J Comput Biol 1997;4:143-56. [PMID: 9228613 DOI: 10.1089/cmb.1997.4.143] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open

Keh GS, Kearney PE, Raper C. Comparison of the beta-adrenoceptor effects of soterenol and its 3-hydroxy, 4-sulphonamido isomer (MJ6987-1) in isolated tissues from the guninea-pig. Clin Exp Pharmacol Physiol 1979;6:409-13. [PMID: 39696 DOI: 10.1111/j.1440-1681.1979.tb00028.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]